Contact
searchSearch
HMP Global

Pain Palliation Topic Center

Featured

Osteocool™ RF Ablation System for Bone Metastases: Clinically Significant Pain Relief and Improved Quality of Life
Jonathan M. Morris, MD discusses the latest research on radiofrequency ablation for painful bone metastases with the OsteoCool System.
02/18/2022
Global Approach to the Patient With Pain in Interventional Oncology
02/16/2022
Dr Chick
Management of SVC Syndrome
02/16/2022
Intractable Ascites & Pleural Effusions: Tunneled Catheters and Denver Shunt
02/16/2022
Celiac Plexus Block and Cryoablation: How I Do It
02/16/2022
Lymphangiograms and Lymphatic Interventions
02/16/2022
The Role of IR in Palliative Care and Hospice
02/16/2022
Dr Jason Levy
Podcast
RFA in Radiation-Naïve Patients for Palliation of Osseous Metastases: A Conversation With Jason Levy, MD, FSIR
01/18/2022
"Best CIO Abstract" Winner Dr Jason Levy discusses an OPuS-One subanalysis that examined subjects who did not receive radiation therapy at the site of RFA before or after RFA treatment.
"Best CIO Abstract" Winner Dr Jason Levy discusses an OPuS-One subanalysis that examined subjects who did not receive radiation therapy at the site of RFA before or after RFA treatment.
"Best CIO Abstract" Winner Dr...
01/18/2022
IO Learning
CIO 2021-2 Radiofrequency Ablation in Radiation Naïve Patients for Palliation of Osseous Metastases: An OPuS One Sub-analysis
Purpose: To report the results from a prospective multicenter study of Radiofrequency Ablation (RFA) for the palliation of painful bone metastases for subjects that did not receive radiat...
11/15/2021
Dr Jason Levy
Podcasts
Twelve-Month Outcomes From the OPuS-One Study: A Conversation With Dr Jason Levy
05/25/2021
This episode of IOL Radio features Dr Jason Levy, lead investigator of the OPuS One trial, which studied the quality of life outcomes from a global, prospective, non-randomized, multicenter study of RFA using Medtronic’s OsteoCool system for...
This episode of IOL Radio features Dr Jason Levy, lead investigator of the OPuS One trial, which studied the quality of life outcomes from a global, prospective, non-randomized, multicenter study of RFA using Medtronic’s OsteoCool system for...
This episode of IOL Radio...
05/25/2021
IO Learning
Dr Jason Levy
Podcasts
The OPuS One Study: Advancing Clinical Evidence in the Treatment of Bone Metastases
12/07/2020
The OsteoCool™ RF Ablation System is a cooled radiofrequency ablation technology that offers simultaneous dual-probe capabilities for treating painful bone tumors. Dr Jason Levy joins us to discuss outcomes on the first 100 patients treated...
The OsteoCool™ RF Ablation System is a cooled radiofrequency ablation technology that offers simultaneous dual-probe capabilities for treating painful bone tumors. Dr Jason Levy joins us to discuss outcomes on the first 100 patients treated...
The OsteoCool™ RF Ablation...
12/07/2020
IO Learning

Subscribe

IO Learning Newsletter

News

News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management
News
Radiation Therapy May Be Potential Heart Failure Treatment
11/28/2023
The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.
The study suggests that low-dose radiation therapy improves heart function, at least in part, by reducing the number of inflammatory immune cells in the heart muscle.
The study suggests that low-dose...
11/28/2023
Cath Lab Digest
News
Canon Medical Introduces Alphenix Sky 12 HD Interventional System
09/12/2023
Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...
Tustin, CA (12 September 2023) — Continuing its focus on providing clinicians with clarity and precision during interventional procedures, Canon Medical Systems Corporation is introducing this technology for the Alphenix Sky 12 HD...
Tustin, CA (12 September 2023) —...
09/12/2023
IO Learning
News
A Retrospective Comparative Study of Chemosat and SIRT Presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting
09/11/2023
New York, NY (11 September 2023) — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced the details of an oral...
New York, NY (11 September 2023) — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced the details of an oral...
New York, NY (11 September 2023)...
09/11/2023
IO Learning
News
Boston Scientific Receives 510(k) Clearance for Expanded Cryoablation System
08/25/2023
Marlborough, MA. (25 August 2023) — Boston Scientific has received 510(k) clearance for expanded indication of the VISUAL ICE cryoablation system. The clearance grants this device an indication expansion to now...
Marlborough, MA. (25 August 2023) — Boston Scientific has received 510(k) clearance for expanded indication of the VISUAL ICE cryoablation system. The clearance grants this device an indication expansion to now...
Marlborough, MA. (25 August...
08/25/2023
IO Learning
News
Delcath Systems Announces FDA Approval of HEPZATO KIT for the Treatment of Adult Patients With Unresectable Hepatic-Dominant Metastatic Uveal Melanoma
08/21/2023
New York, NY. (21 August 2023) — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced that today the US Food and Drug...
New York, NY. (21 August 2023) — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced that today the US Food and Drug...
New York, NY. (21 August 2023)...
08/21/2023
IO Learning
News
HMP Global Earns Healthcare Industry Top Workplaces Award for Company Culture, Employee Satisfaction
08/18/2023
Malvern, PA (18 August 2023) — HMP Global, the leading omnichannel events and education company, is one of only 111 companies nationwide to earn a 2023 Healthcare Industry Top Workplaces award, its fifth award this year based on employee...
Malvern, PA (18 August 2023) — HMP Global, the leading omnichannel events and education company, is one of only 111 companies nationwide to earn a 2023 Healthcare Industry Top Workplaces award, its fifth award this year based on employee...
Malvern, PA (18 August 2023)...
08/18/2023
IO Learning
News
Siemens Healthineers Announces Partnership With SSM Health
08/14/2023
Erlangen, Germany (14 August 2023) —SSM Health and Siemens Healthineers have announced a new 10-year strategic partnership agreement focused on expanding access to high-quality care and training the next generation of health care...
Erlangen, Germany (14 August 2023) —SSM Health and Siemens Healthineers have announced a new 10-year strategic partnership agreement focused on expanding access to high-quality care and training the next generation of health care...
Erlangen, Germany (14 August...
08/14/2023
IO Learning
News
Interventional Oncology Accreditation Program IASIOS Continues to Reach new Heights
08/11/2023
Vienna, Austria (11 August 2023) — The only accreditation system of its kind has nearly tripled its network of esteemed interventional oncology centers worldwide since launching in 2021.The International Accreditation System...
Vienna, Austria (11 August 2023) — The only accreditation system of its kind has nearly tripled its network of esteemed interventional oncology centers worldwide since launching in 2021.The International Accreditation System...
Vienna, Austria (11 August 2023)...
08/11/2023
IO Learning
News
Accuray Receives FDA 510(k) Clearance for its VitalHold™ on the Radixact® System
08/10/2023
Madison, WI (10 August 2023) — Accuray Incorporated has announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its VitalHold™* breast package on...
Madison, WI (10 August 2023) — Accuray Incorporated has announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its VitalHold™* breast package on...
Madison, WI (10 August 2023)...
08/10/2023
IO Learning

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use